CoChat

Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Pseudomonas aeruginosa is a major pathogen in cystic fibrosis (CF) lung disease. Children with CF are routinely exposed to P. aeruginosa from the natural environment, and by adulthood, 80% of patients are chronically infected.P. aeruginosa in the CF airway exhibits a unique biofilm-like structure, where it grows in small clusters or aggregates of bacteria in association with abundant polymers of neutrophil-derived components F-actin and DNA, among other components. These aggregates differ substantially in size and appearance compared to surface-attached in vitro biofilm models classically utilized for studies but are believed to share properties of surface-attached biofilms, including antibiotic resistance. However, little is known about the formation and function of surface-independent modes of biofilm growth, how they might be eradicated, and quorum sensing communication. To address these issues, we developed a novel in vitro model of P. aeruginosa aggregates incorporating human neutrophil-derived products. Aggregates grown in vitro and those found in CF patients' sputum samples were morphologically similar; viable bacteria were distributed in small pockets throughout the aggregate. The lasA quorum sensing gene was differentially expressed in the presence of neutrophil products. Importantly, aggregates formed in the presence of neutrophils acquired resistance to tobramycin, which was lost when the aggregates were dispersed with DNase, and antagonism of tobramycin and azithromycin was observed. This novel yet simple in vitro system advances our ability to model infection of the CF airway and will be an important tool to study virulence and test alternative eradication strategies against P. aeruginosa.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.03514-14

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 3

  1. Cystic Fibrosis Foundation. 2013. Cystic Fibrosis Foundation patient registry. 2012 annual data report to the center directors. Cystic Fibrosis Foundation, Bethesda, MD.
  2. HaslettCGuthrieLAKopaniakMJohnstonRBJrHensonPM. 1985. Modulation of multiple neutrophil functions by trace amounts of bacterial LPS and by preparative methods. Am. J. Pathol. 119:101–110.
  3. Cystic Fibrosis Therapeutics Development Network Coordinating Center. 2013. Sputum processing for cytology and inflammatory markers: SOP 508. Cystic Fibrosis Therapeutics Development Network Coordinating Center, Bethesda, MD.

Cited by

See all 50

Metadata

Authors
Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A.
Affiliations
  • National Jewish Health (US)
  • Department of Medicine, National Jewish Health, Denver, Colorado, USA
  • Harvard University (US)
  • Seattle Children's Hospital (US)
Venue
Antimicrobial Agents and Chemotherapy
Published
2014-11
Volume
58
Issue
11
Pages
6851-6860
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2130663948
Cited by
50
References
61
Citations by year
2025: 2 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 14 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 4
FWCI
1.64
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Genentech
  • National Heart, Lung, and Blood Institute (HL34303, P01HL034303)
  • National Institute of Allergy and Infectious Diseases (R01AI110408)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK089507)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
Pseudomonas aeruginosa, cystic fibrosis, bacterial aggregates, antibiotic resistance, tobramycin, azithromycin, quorum sensing, F-actin, DNA, in vitro biofilm model, sputum, DNase, virulence
MeSH terms
Anti-Bacterial Agents, Cystic Fibrosis, Humans, Microbial Sensitivity Tests, Neutrophils, Pseudomonas aeruginosa, Pseudomonas Infections, Sputum, Tobramycin, Azithromycin, Biofilms, Drug Resistance, Multiple, Bacterial, Virulence Factors, Metalloproteases, Quorum Sensing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products. https://app.cochat.ai/papers/10.1128/aac.03514-14
The paper
Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A. (2014). Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.03514-14

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.